Skip to main content
SpringerLink
Log in

HIV PrEP in people who inject drugs is expensive in US

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2015 US dollars

References

  1. Bernard CL, et al. Cost-Effectiveness of HIV Preexposure Prophylaxis for People Who Inject Drugs in the United States. Annals of Internal Medicine : 26 Apr 2016. Available from: URL: http://doi.org/10.7326/M15-2634

    PubMed  Google Scholar 

  2. Walensky RP. Investing in People Who Inject Drugs: A PrEPonderance of Opportunities. Annals of Internal Medicine : 26 Apr 2016. Available from: URL: http://dx.doi.org/10.7326/M16-0788

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HIV PrEP in people who inject drugs is expensive in US. PharmacoEcon Outcomes News 752, 19 (2016). https://doi.org/10.1007/s40274-016-3013-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3013-5

Search

Navigation